POLARIS (Stargardt Disease Type 1) - Clinical Trial
What is the Purpose of this Study?
We are doing this study to gather information on Stargardt Disease Type 1 (STGD1) and how it develops over time.
What is the Condition Being Studied?
Stargardt Disease Type 1
Who Can Participate in the Study?
Children and adults ages 12-65 who:
- Are diagnosed with STGD1
- Have no other eye disease, like cataracts, that would affect the procedures
- Have no history of amblyopia (lazy eyes)
For more information about who can be in this study, please contact the study team at DEC-RA@duke.edu or 919-660-3520.
Age Group
Adults, Children
What is Involved?
If you choose to join this observational study, you will:
- Keep in touch with the study team for about 96 weeks (8 years)
- Visit our clinic at the Duke Eye Center up to 6 times
At various visits, you will answer some questionnaires, and have eye exams and vision tests.
Study Details
Full Title
An Observational Study in Subjects to Follow the Progression of Stargardt Disease Type 1 (STGD1) Caused by Bi-Allelic Autosomal Recessive Mutations in the ATP Binding Cassette Subfamily A Member 4 (ABCA4) Gene - POLARIS
Principal Investigator
Ophthalmologist
Protocol Number
IRB:
PRO00115342
NCT:
NCT06435000
Phase
Phase
N/A
ClinicalTrials.gov
View on ClinicalTrials.gov
Enrollment Status
Open for Enrollment